A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS
Clinical trial NCT03059615 · WITHDRAWN
Trial details
- NCT number
- NCT03059615
- Sponsor
- Immune System Key Ltd
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2020-07-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.